Classification of Pharmaceutical Policy Measures During the Portuguese Financial Crisis.

Autor: Donato AA; School of Pharmacy, Laboratory of Social Pharmacy and Public Health, University of Coimbra Faculty of Pharmacy, Coimbra, Portugal., Pita JR; School of Pharmacy, Laboratory of Social Pharmacy and Public Health, University of Coimbra Faculty of Pharmacy, Coimbra, Portugal., Batel-Marques F; School of Pharmacy, Laboratory of Social Pharmacy and Public Health, University of Coimbra Faculty of Pharmacy, Coimbra, Portugal.
Jazyk: angličtina
Zdroj: Inquiry : a journal of medical care organization, provision and financing [Inquiry] 2022 Jan-Dec; Vol. 59, pp. 469580221093171.
DOI: 10.1177/00469580221093171
Abstrakt: Background: A rise in pharmaceutical expenses in Portugal led to the introduction of policy measures aimed at controlling outpatient public costs. This research examines and categorizes the most common pharmaceutical measures implemented during the Troika intervention, as well as comparing this period of time to prior ones.
Methods: A hierarchical structure of descriptors was built to classify and group measures over a 20-year period, including whether they might be deemed austerity measures. The nature, relative weight, and frequency of measures, along with the evolution of public drug expenditure, were assessed.
Results: Although there were fluctuations, frequency tended to increase. The highest number of policy changes per year was in 2010, a year before the financial assistance. The Troika intervention was characterized by a strong emphasis on pricing and prescription-related initiatives. Generic medicines played a significant role in the effort to reduce public drug expenditure.
Conclusions: During the Troika intervention, outpatient public drug expenditure was consistently reduced through a comprehensive "package of measures" aimed at both the demand and supply sides. The effectiveness of some previous independent measures, if any, was temporary.
Databáze: MEDLINE
Externí odkaz: